734-660-8152 [email protected]

Intent Impact Fund: Helping the world tackle brain health

Intent® Impact Fund’s Mission is to promote brain health as a global, non-profit/501(c)3 public charity leader in education, commercialization, small business investment & advocacy activities. Intent® does this by advancing the prevention, diagnosis & treatment of Traumatic Brain Injury (TBI), long COVID, neurologic/spine/neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimer’s, amyotrophic lateral sclerosis (ALS), Parkinson’s, Epilepsy, Huntington’s, brain development impacts due to lead/contaminant exposures, stroke and Central Nervous System (CNS) cancers with mindful attention to mental health. Intent® accomplishes this goal through advocacy, education, and by directly providing one-of-a-kind support of commercialization endeavors for promising research & technology platforms. 

Nature affords us many opportunities to view the world from a new perspective, utilize uncommon approaches and to mobilize investment in brain health technology-focused platforms & small businesses that can help to prevent, diagnose and treat many neurologic conditions. Intent® envisions a world where, like the horizon-viewing giraffe long-standing in our logo, we support our entrepreneurs and charitable beneficiaries to see beyond obstructions – along a future-facing horizon. Giraffes remain symbolic to our mission as they are born with advanced brain stems/nervous systems and thick skulls, possessing incredible physiology that enables them to withstand extraordinary conditions such as a brain-injury force and/or fully inverted neck with retained neurologic & hemodynamic stability.



Donate today to start helping with preventative brain health

Learn about our emerging portfolio approaches

Information on the epidimiology of brain conditions

We support diverse entrepreneurs & prioritize businesses as well as platform technologies in brain health domains that revolutionize the care continuum while eliminating inequities in prevention, diagnosis and treatment.

Two thirds of Alzheimer’s patients are women, four times as many women have multiple sclerosis (MS) as men, more women are now known to be suffering from long COVID, women suffer and recover differently than men from Traumatic Brain Injuries (TBIs)/concussions.  Female founders lag behind male counterparts in securing commercialization capital in these domains but are arguably more successful at attaining exits and clearing clinical milestones once funded.  Intent Impact Fund 501c3 uniquely strives to eradicate brain health disparities.

Overcome healthcare limitations

Intelligently embrace R&D and product validation risks

Catalyze economic returns across broad geographies

Revolutionize the care continuum

Enhance patient welfare and/or extend longevity

We work directly and methodically to deliver RESULTS and RETURNS through our background and experiences: 

Network Advantages

We are especially well-networked, providing a competitive advantage for identifying valuable opportunities early.

Experience in identifying promising technology, securing early and non-dilutive funding & helping to advance technology from labs to the market across healthcare and medical technology ecosystems.

Leading Experience

Uniquely qualified to assemble advisory boards for ventures, providing access to skills and insight needed at each stage of development.

We know where to find and how to engage the needed experts and advisors to meet informational needs at all stages of the venture’s growth on the path to exit.

Growth Experts

Active coaching/mentoring role with milestone definition/monitoring.

A history of both direct leadership and consultation in the sectors.

Intent Capital Leadership

The Intent® Team is supported by a diverse group of clinical, technology and market-sector advisors.

Lindsay E. Klee | Founding and Managing Partner
Lindsay advises investor, R&D, life science and healthcare clients nationally. Lindsay has consulted for VC investors, manufacturers, payors, startups, has worked as part of the Belle Michigan LP General Partnership, consulted with numerous hospitals and has served as Executive Director, Managing Director, Commercialization Director for a variety of research institute/healthcare/university enterprises. She has created and directed multi-million dollar, private technology gap funding initiatives. She secured competitive capital for and managed an FDA-sponsored device and diagnostics consortium and privately assists teams and companies working toward product milestones, revenue growth, reimbursement/coding/coverage, funding and FDA submissions/compliance. Lindsay’s previous work experience also includes consulting for small, medium, and large enterprises (both independently and within the Healthcare and Life Science Divisions of PricewaterhouseCoopers, LLC). Her consulting efforts have focused on M&A/expansion decisions, deal structuring, feasibility studies, financial and business/commercial planning, reimbursement, clinical evidence/trials and regulatory compliance. She also has worked in technology transfer and in drug discovery as a scientist with Pfizer Global Research and Development.

Lindsay’s skill set is associated with multi-functional team leadership, technology revenue growth strategies/execution, payor/insurance advocacy, FDA compliance, deal strategy, healthcare operations, financial management, portfolio management, early-stage product development, & inter-disciplinary communications involving investors, C-suite/fiscal executives, entrepreneurs, scientists, academic administrators, payors, and physicians.


Contact Us: